CytomX Therapeutics (CTMX) EBITDA Margin Growth (5y) (2019 - 2026)
CytomX Therapeutics (CTMX) EBITDA Margin Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,371.00 |
| Dec 31, 2025 | -387,285.00 |
| Sep 30, 2025 | 7,333.00 |
| Jun 30, 2025 | 36,171.00 |
| Mar 31, 2025 | 5,614.00 |
| Dec 31, 2024 | 86,735.00 |
| Sep 30, 2024 | 25,238.00 |
| Jun 30, 2024 | 31,288.00 |
| Mar 31, 2024 | 11,963.00 |
| Dec 31, 2023 | 22,273.00 |
| Sep 30, 2023 | 19,712.00 |
| Jun 30, 2023 | 12,037.00 |
| Mar 31, 2023 | 8,614.00 |
| Dec 31, 2022 | -4,264.00 |
| Sep 30, 2022 | -22,087.00 |
| Jun 30, 2022 | 5,608.00 |
| Mar 31, 2022 | -28,075.00 |
| Dec 31, 2021 | -8,666.00 |
| Sep 30, 2021 | 9,406.00 |
| Jun 30, 2021 | 15,727.00 |